IL256585B - Topical formulations of diacerein or rhein and their uses - Google Patents
Topical formulations of diacerein or rhein and their usesInfo
- Publication number
- IL256585B IL256585B IL256585A IL25658517A IL256585B IL 256585 B IL256585 B IL 256585B IL 256585 A IL256585 A IL 256585A IL 25658517 A IL25658517 A IL 25658517A IL 256585 B IL256585 B IL 256585B
- Authority
- IL
- Israel
- Prior art keywords
- diacerein
- rhein
- topical formulations
- topical
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187743P | 2015-07-01 | 2015-07-01 | |
| PCT/US2016/040287 WO2017004319A1 (en) | 2015-07-01 | 2016-06-30 | Diacerein or rhein topical formulations and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL256585A IL256585A (en) | 2018-02-28 |
| IL256585B true IL256585B (en) | 2021-05-31 |
Family
ID=57609470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL256585A IL256585B (en) | 2015-07-01 | 2017-12-26 | Topical formulations of diacerein or rhein and their uses |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9744131B2 (enExample) |
| EP (1) | EP3316879A4 (enExample) |
| JP (3) | JP7577428B2 (enExample) |
| KR (1) | KR102702557B1 (enExample) |
| CN (2) | CN107921013A (enExample) |
| AU (2) | AU2016287636B2 (enExample) |
| CA (1) | CA2990948C (enExample) |
| HK (1) | HK1249057A1 (enExample) |
| IL (1) | IL256585B (enExample) |
| MX (1) | MX373702B (enExample) |
| TW (1) | TWI723032B (enExample) |
| WO (1) | WO2017004319A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180037261A (ko) * | 2015-08-17 | 2018-04-11 | 티더블유아이 바이오테크놀로지 인코포레이티드 | Asc의 발현, nlrp3의 발현, 및/또는 nlrp3 인플라마솜 복합체의 형성 저해용 디아세레인 또는 이의 유사체 |
| EP3570835B1 (en) * | 2017-01-19 | 2023-08-09 | TWI Biotechnology, Inc. | Diacerein for preventing or treating immunoinflammatory dermal disorders |
| CN106692037B (zh) * | 2017-01-24 | 2020-02-18 | 中南大学湘雅医院 | 大黄酸超分子水凝胶及其制备方法和应用 |
| CN107823126B (zh) * | 2017-12-04 | 2020-03-24 | 广东药科大学 | 双醋瑞因注射型温敏凝胶及其制备方法 |
| CN111265508B (zh) * | 2018-12-05 | 2022-03-25 | 中检科医药科技(北京)集团有限公司 | 双醋瑞因在制备抗病毒药物及治疗病毒感染中的用途 |
| CN109758421A (zh) * | 2019-03-27 | 2019-05-17 | 毕波 | 一种蓝氧抗菌灭毒软膏及其制备方法 |
| US20220265577A1 (en) * | 2019-08-03 | 2022-08-25 | Venkateswarlu Vobalaboina | Process for the preparation of anthraquinone topical formulation |
| CN110585120B (zh) * | 2019-10-08 | 2020-11-27 | 中南大学 | 一种可注射双醋瑞因水凝胶及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4018764B2 (ja) * | 1996-10-18 | 2007-12-05 | 正規 小菅 | 津液改善用皮膚外用剤 |
| FR2757397B1 (fr) | 1996-12-23 | 1999-03-05 | Mazal Pharma | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree |
| US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
| US20100285114A1 (en) * | 2007-09-27 | 2010-11-11 | Rahul Dabre | Pharmaceutical compositions of rhein or diacerein |
| US20090093509A1 (en) * | 2007-10-08 | 2009-04-09 | Tahir Nazir | Methods and Compositions for the Treatment of Pruritus |
| WO2009133430A1 (en) * | 2008-04-30 | 2009-11-05 | Wockhardt Research Centre | Topical compositions of rhein or diacerein |
| TWI473610B (zh) * | 2008-10-28 | 2015-02-21 | Twi Biotechnology Inc | 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物 |
| FR2949044B1 (fr) * | 2009-08-12 | 2021-05-07 | Expanscience Lab | Composition comprenant une fraction d'insaponifiable |
| MX2012011517A (es) | 2010-04-08 | 2012-11-29 | Twi Biotechnology Inc | El uso de diacereina como una terapia adyuvante para diabetes. |
| WO2012013670A1 (en) * | 2010-07-29 | 2012-02-02 | University Of Geneva | Process for the esterification of hyaluronic acid with hydrophobic organic compounds |
| JP6012639B2 (ja) | 2011-03-11 | 2016-10-25 | ティダブリューアイ・バイオテクノロジー・インコーポレイテッドＴＷＩ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ， Ｉｎｃ． | 高尿酸血症および高尿酸血症関連代謝障害を治療するための方法および組成物 |
-
2016
- 2016-06-30 US US15/198,728 patent/US9744131B2/en active Active
- 2016-06-30 JP JP2017568131A patent/JP7577428B2/ja active Active
- 2016-06-30 AU AU2016287636A patent/AU2016287636B2/en active Active
- 2016-06-30 CN CN201680050004.8A patent/CN107921013A/zh active Pending
- 2016-06-30 HK HK18108955.6A patent/HK1249057A1/zh unknown
- 2016-06-30 EP EP16818753.2A patent/EP3316879A4/en active Pending
- 2016-06-30 CN CN202311670907.4A patent/CN117482078A/zh active Pending
- 2016-06-30 KR KR1020187002677A patent/KR102702557B1/ko active Active
- 2016-06-30 CA CA2990948A patent/CA2990948C/en active Active
- 2016-06-30 MX MX2018000264A patent/MX373702B/es active IP Right Grant
- 2016-06-30 WO PCT/US2016/040287 patent/WO2017004319A1/en not_active Ceased
- 2016-07-01 TW TW105120973A patent/TWI723032B/zh active
-
2017
- 2017-12-26 IL IL256585A patent/IL256585B/en active IP Right Grant
-
2021
- 2021-09-08 AU AU2021229177A patent/AU2021229177B2/en active Active
-
2022
- 2022-08-05 JP JP2022125318A patent/JP7578651B2/ja active Active
-
2024
- 2024-07-29 JP JP2024122108A patent/JP2024164022A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3316879A4 (en) | 2019-01-23 |
| CN107921013A (zh) | 2018-04-17 |
| AU2016287636A1 (en) | 2018-02-08 |
| US20170000732A1 (en) | 2017-01-05 |
| JP2018522875A (ja) | 2018-08-16 |
| CA2990948C (en) | 2024-09-10 |
| WO2017004319A1 (en) | 2017-01-05 |
| JP2022169600A (ja) | 2022-11-09 |
| JP7578651B2 (ja) | 2024-11-06 |
| TW201717932A (zh) | 2017-06-01 |
| EP3316879A1 (en) | 2018-05-09 |
| CN117482078A (zh) | 2024-02-02 |
| JP7577428B2 (ja) | 2024-11-05 |
| JP2024164022A (ja) | 2024-11-26 |
| MX373702B (es) | 2020-05-07 |
| US9744131B2 (en) | 2017-08-29 |
| KR20180023965A (ko) | 2018-03-07 |
| TWI723032B (zh) | 2021-04-01 |
| MX2018000264A (es) | 2018-05-23 |
| AU2021229177A1 (en) | 2021-10-07 |
| CA2990948A1 (en) | 2017-01-05 |
| KR102702557B1 (ko) | 2024-09-03 |
| AU2021229177B2 (en) | 2023-11-23 |
| IL256585A (en) | 2018-02-28 |
| AU2016287636B2 (en) | 2021-09-16 |
| HK1249057A1 (zh) | 2018-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202007965B (en) | Topical pharmaceutical compositions | |
| ZA201800080B (en) | Topical retinoid compositions | |
| GB2535911B (en) | Strigolactone formulations and uses thereof | |
| SG11201701292XA (en) | Topical formulation | |
| IL256585B (en) | Topical formulations of diacerein or rhein and their uses | |
| PL3349720T3 (pl) | Biopochodna kompozycja emolientowa zawierająca izoparafiny | |
| ZA201904704B (en) | Topical cyclosporine-containing formulations and uses thereof | |
| EP3328353A4 (en) | TOPICAL SKIN FORMULATIONS | |
| IL248934A0 (en) | Topical formulations and their uses | |
| EP3383912A4 (en) | TOPICAL FORMULATIONS | |
| PT3324938T (pt) | Formulações tópicas e tratamentos | |
| GB201709918D0 (en) | Topical formulation | |
| EP3328354A4 (en) | TOPICAL SKIN FORMULATIONS | |
| IL260050B (en) | Dendrimers and preparations containing them | |
| GB201502845D0 (en) | Topical pharmaceutical formulation | |
| IL254241A0 (en) | Etv2 and its uses | |
| PT3373976T (pt) | Formulações tópicas e suas utilizações | |
| GB201508474D0 (en) | Improvements in or relating to field devices | |
| GB201400647D0 (en) | Topical composition | |
| PL3313369T3 (pl) | Kompozycja emolientu | |
| ZA201605935B (en) | Topical antibiotic formulations | |
| GB201513108D0 (en) | Topical composition | |
| TR201512960A1 (tr) | Topi̇kal formülasyonlar | |
| GB201522814D0 (en) | Compositions and uses thereof | |
| AU5536P (en) | EREM1 Eremophila glabra |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted |